Stem Cell Research
GPI Applauds Cloned Stem Cell Breakthrough in Primates
Published in Medical Device Law Weekly, December 2nd, 2007
"The creation of cloned stem cell lines in primates is a milestone," said Bernard Siegel, executive director of the Genetics Policy Institute. "Stem cells derived in this fashion in humans could lead to cell therapies using a patient's own cells and thereby avoid the problems on immune suppression. In the future, researchers may create cloned cell lines from patients burdened by diabetes and other diseases. Such cells could be studied to determine the root causes for disease...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Arthroscopy
Researchers from Loyola Marymount University report details of new studies and findings in the area of arthroscopy - Defibrillators
Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT - Toxicology
Studies from M. del Mar Ramirez Fernandez and co-authors have provided new information about toxicology - Adrenalectomy
Reports outline adrenalectomy study results from University of Toronto - Algorithms
New findings reported from University of Limerick, Department of Physics describe advances in algorithms - Allergies
HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
